COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,580 Articles (22,415 medRxiv, 8,165 bioRxiv)

Most recent first Previous |  Page 953: Articles 9521-9530  | Next

Vaccines Elicit Highly Cross-Reactive Cellular Immunity to the SARS-CoV-2 Omicron Variant
Liu, J., Chandrashekar, A., Sellers, D., Barrett, J., Lifton, M., McMahan, K., Sciacca, M., VanWyk, H., Wu, C., Yu, J., Collier, A.-r., Barouch, D. H.
10.1101/2022.01.02.22268634 — Posted: 2022-01-03 Discussion: Onsite
Integrin/TGF-Beta1 inhibitor GLPG-0187 blocks SARS-CoV-2 Delta and Omicron pseudovirus infection of airway epithelial cells which could attenuate disease severity
Huntington, K. E., Carlsen, L., So, E.-Y., Piesche, M., Liang, O., El-Deiry, W.
10.1101/2022.01.02.22268641 — Posted: 2022-01-03
Statistical and agent-based modelling of the transmissibility of different SARS-CoV-2 variants in England and impact of different interventions
Panovska-Griffiths, J., Swallow, B., Hinch, R., Cohen, J. A., Rosenfeld, K., Stuart, R. M., Ferretti, L., Di Lauro, F., Wymant, C., Izzo, A., Waites, W., Viner, R. M., Bonell, C., The COVID-19 Genomics UK (COG-UK) consortium, , Fraser, C., Klein, D. J., Kerr, C.
10.1101/2021.12.30.21267090 — Posted: 2022-01-03
Estimating protection afforded by prior infection in preventing reinfection: Applying the test-negative study design
Ayoub, H. H., Tomy, M., Chemaitelly, H., Altarawneh, H. N., Coyle, P., Tang, P., Hasan, M. R., Al Kanaani, Z., Al Kuwari, E., Butt, A. A., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Nasrallah, G., Benslimane, F., Al Khatib, H. A., YASSINE, H. M., Al Kuwari, M. G., Al Romaihi, H. E., Abdul-Rahim, H. F., Al-Thani, M. H., Al Khal, A., Bertollini, R., Abu-Raddad, L. J.
10.1101/2022.01.02.22268622 — Posted: 2022-01-03
Estimation the state of the Covid-19 epidemic curve in Mayotte
MANOU-ABI, S. M., SLAOUI, Y., BALICCHI, J.
10.1101/2021.12.30.21268571 — Posted: 2022-01-03
Cognitive predictors of vaccine hesitancy and COVID-19 mitigation behaviors in a population representative sample
Hudson, A., Hall, P. A., Hitchman, S., Meng, G., Fong, G. T.
10.1101/2022.01.02.22268629 — Posted: 2022-01-03
Expanded ACE2 dependencies of diverse SARS-like coronavirus receptor binding domains
Roelle, S. M., Shukla, N., Pham, A. T., Bruchez, A. M., Matreyek, K. A.
10.1101/2021.12.25.474149 — Posted: 2022-01-03
Potential application of Rapid Antigen Diagnostic Tests for the detection of infectious individuals attending mass gatherings: a simulation study
McAloon, C. G., Dahly, D., Walsh, C., Wall, P., Smyth, B., More, S. J., Teljeur, C.
10.1101/2022.01.02.22268621 — Posted: 2022-01-02
SARS-CoV-2 screening in patients in need of urgent inpatient treatment in the Emergency Department (ED) by digitally integrated point-of-care PCR: A clinical cohort study
Mockel, M., Bolanaki, M., Hofmann, J., Stein, A., Hitzek, J., Holert, F., Fischer-Rosinsky, A., Slagman, A.
10.1101/2022.01.01.22268603 — Posted: 2022-01-02
Preserved recognition of Omicron Spike following COVID-19 mRNA vaccination in pregnancy
Bartsch, Y. C., Atyeo, C., Kang, J., Gray, K. J., Edlow, A. G., Alter, G.
10.1101/2022.01.01.22268615 — Posted: 2022-01-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).